Taking AI and machine learning to whole new fields
When it comes to applying artificial intelligence (AI) and machine learning to medical imaging, ContextVision has always been ahead of its field. Over the last decades, the company’s pioneering technologies have evolved into a highly sophisticated portfolio of solutions for Ultrasound’s, X-ray’s, MRI’s, and more.
Altumira — now even more powerful
One of the company’s most successful solutions is Altumira, a powerful software that draws on advanced AI to take X-ray images to a whole new level. This year’s RSNA sees the unveiling of Altumira’s new, impressive scatter correction functionality, allowing for exceptional quality in images acquired without a physical grid. In addition, Altumira Plus — for dynamic imaging — will be upgraded with improved noise suppression and enhanced visualization of details, e.g., stents and vessels.
Transforming the future of healthcare
Today, ContextVision operates on a global scale, serving healthcare institutions and professionals around the world. While innovation has always been a strong driving force, so has a genuine concern for the overall transformation of healthcare.
“By continuously staying ahead of technological advancements, we can not only improve the quality of medical imaging, but also help transform patient care all over the world,” says Gerald Pötzsch, CEO of ContextVision.
Join ContextVision at RSNA
At RSNA 2023, ContextVision will be celebrating its 40th anniversary and demonstrating its latest innovations, including the new Altumira features. Join them at Booth #6802. For more info, contact Gerald Pötzsch, CEO at gerald.potzsch@contextvision.com or visit www.contextvision.com.
About ContextVision
ContextVision is a medical technology software company specialized in image analysis and artificial intelligence. As the global market leader within image enhancement, we are a trusted partner to leading manufacturers of ultrasound, X-ray and MRI equipment around the world. Our expertise is to develop powerful software products, based on proprietary technology and artificial intelligence for image-based applications. The company’s cutting-edge technology helps clinicians accurately interpret medical images, a crucial foundation for better diagnosis and treatment. The company, established in 1983, is based in Sweden with local representation in the U.S., Japan, China, and Korea. ContextVision is listed on the Oslo Stock Exchange under the ticker CONTX.